Dermata Therapeutics Stock (NASDAQ: DRMAW) stock price, news, charts, stock research, profile.
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMAW) through any online brokerage.
Other companies in Dermata Therapeutics’s space includes: BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
There is no analysis for Dermata Therapeutics to provide a consensus price target.
The stock price for Dermata Therapeutics (NASDAQ: DRMAW) is $0.0197 last updated January 3, 2025 at 5:47 PM EST.
There are no upcoming dividends for Dermata Therapeutics.
Dermata Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Dermata Therapeutics.
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.